nifedipine has been researched along with Lung Diseases in 16 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In threatened preterm labor, maintenance tocolysis with nifedipine, after an initial course of tocolysis and corticosteroids for 48 hours, may improve perinatal outcome." | 2.78 | Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. ( Bloemenkamp, KW; Bolte, AC; Cornette, J; de Groot, CJ; Duvekot, JJ; Franssen, MT; Kok, JH; Kwee, A; Lotgering, FK; Merién, A; Mol, BW; Nij Bijvank, B; Opmeer, BC; Oudijk, MA; Papatsonis, DN; Porath, MM; Roos, C; Scheepers, HC; Scherjon, SA; Schuit, E; Sollie, KM; Spaanderman, ME; van der Post, JA; van Eyck, J; van Pampus, MG; Vijgen, SM; Willekes, C, 2013) |
| "Treatment with nifedipine did not significantly change any of the pulmonary function values, except for the carbon monoxide diffusing capacity (DLCO)." | 1.28 | Diffusing capacity of the lung and nifedipine in systemic sclerosis. ( Georgiakodis, F; Kyriakidis, M; Papazoglou, S; Sfikakis, P; Sfikakis, PP; Toutouzas, P; Vergos, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roos, C | 1 |
| Spaanderman, ME | 1 |
| Schuit, E | 1 |
| Bloemenkamp, KW | 1 |
| Bolte, AC | 1 |
| Cornette, J | 1 |
| Duvekot, JJ | 1 |
| van Eyck, J | 1 |
| Franssen, MT | 1 |
| de Groot, CJ | 1 |
| Kok, JH | 1 |
| Kwee, A | 1 |
| Merién, A | 1 |
| Nij Bijvank, B | 1 |
| Opmeer, BC | 1 |
| Oudijk, MA | 1 |
| van Pampus, MG | 1 |
| Papatsonis, DN | 1 |
| Porath, MM | 1 |
| Scheepers, HC | 1 |
| Scherjon, SA | 1 |
| Sollie, KM | 1 |
| Vijgen, SM | 1 |
| Willekes, C | 1 |
| Mol, BW | 1 |
| van der Post, JA | 1 |
| Lotgering, FK | 1 |
| Karlsberg, RP | 1 |
| Okada, O | 2 |
| Naitou, T | 1 |
| Katou, K | 1 |
| Tanabe, N | 1 |
| Kouchi, F | 1 |
| Yamagishi, F | 2 |
| Sugita, T | 2 |
| Kuriyama, T | 2 |
| Watanabe, S | 2 |
| Bergemann, A | 1 |
| Tikly, M | 1 |
| Sfikakis, PP | 1 |
| Kyriakidis, M | 1 |
| Vergos, C | 1 |
| Papazoglou, S | 1 |
| Georgiakodis, F | 1 |
| Toutouzas, P | 1 |
| Sfikakis, P | 1 |
| Berman, BA | 1 |
| Ross, RN | 1 |
| Sawada, M | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| du Toit, HJ | 1 |
| Macfarlane, CM | 1 |
| Taljaard, JJ | 1 |
| King, JB | 1 |
| Cooper, RC | 1 |
| Zhao, MW | 1 |
| Mutoh, T | 1 |
| Akamine, N | 1 |
| Hachisuka, H | 1 |
| Abe, M | 1 |
| Ohkuma, A | 1 |
| Sugiyama, T | 1 |
| Izumi, T | 1 |
| Akashiba, T | 1 |
| Hosakawa, Y | 1 |
| Horie, T | 1 |
| Vereshchagina, GN | 1 |
| Vasilenko, GP | 1 |
| Kuleshova, TV | 1 |
| Grisanti, M | 1 |
| Vicencio, M | 1 |
| Naito, T | 1 |
| Kohchi, F | 1 |
| Michael, JR | 1 |
| Selinger, S | 1 |
| Parham, W | 1 |
| Buescher, P | 1 |
| Wong, D | 1 |
| Kennedy, TP | 1 |
| Ohar, J | 1 |
| Polatty, C | 1 |
| Robichaud, A | 1 |
| Fowler, A | 1 |
| Vetrovec, G | 1 |
| Glauser, F | 1 |
2 reviews available for nifedipine and Lung Diseases
| Article | Year |
|---|---|
Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma, Exercise-Induced; Bronchial Spasm; Calcium; Ca | 1986 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
2 trials available for nifedipine and Lung Diseases
| Article | Year |
|---|---|
Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Enterocolitis, Necrotizing; Female; Fetal | 2013 |
Aetiology of pulmonary dysfunction in total hip replacement operations. The influence of nifedipine on the factors involved.
Topics: Aged; Aged, 80 and over; beta-Thromboglobulin; Clinical Trials as Topic; Complement C5; Double-Blind | 1987 |
12 other studies available for nifedipine and Lung Diseases
| Article | Year |
|---|---|
Welcome--the calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blocker | 1981 |
[Pulmonary hemodynamic effects of cold pressor test in patients with chronic lung disease].
Topics: Chronic Disease; Cold Temperature; Female; Hemodynamics; Humans; Lung Diseases; Male; Middle Aged; N | 1993 |
Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.
Topics: Adult; Antirheumatic Agents; Cysts; Female; Humans; Lung Diseases; Nifedipine; Penicillamine; Pulmon | 1996 |
Diffusing capacity of the lung and nifedipine in systemic sclerosis.
Topics: Adult; Carbon Monoxide; Drug Administration Schedule; Female; Hemodynamics; Humans; Lung Diseases; M | 1990 |
Oxygen therapy and vasodilator therapy in patients with chronic lung disease: the effects of episodic pulmonary hypertension during sleep and exercise performance.
Topics: Blood Pressure; Chronic Disease; Exercise Test; Hemodynamics; Humans; Hypertension, Pulmonary; Isoso | 1989 |
[Therapeutic effect of nifedipine on the rabbit after injection of oleic acid].
Topics: Animals; Female; Hemodynamics; Lung Diseases; Male; Nifedipine; Oleic Acid; Oleic Acids; Rabbits | 1988 |
[Effect of low flow oxygen and nifedipine on ventilation and hemodynamics in chronic lung diseases].
Topics: Chronic Disease; Female; Hemodynamics; Humans; Lung Diseases; Male; Nifedipine; Oxygen Consumption; | 1988 |
[Effectiveness of calcium antagonists in the treatment of patients with chronic nonspecific lung diseases].
Topics: Adult; Aged; Aminophylline; Calcium Channel Blockers; Chronic Disease; Cinnarizine; Drug Evaluation; | 1988 |
[Pulmonary involvement in progressive systemic sclerosis].
Topics: Humans; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Penicillamine; Pulmonary Fibrosis; Scler | 1986 |
[Hemodynamic and gas exchange effects of nifedipine in patients with chronic pulmonary disease].
Topics: Female; Hemodynamics; Hypertension, Pulmonary; Lung Diseases; Male; Nifedipine; Pulmonary Gas Exchan | 1986 |
Use of calcium channel blockers in hypoxic lung disease.
Topics: Calcium Channel Blockers; Humans; Hypoxia; Lung Diseases; Lung Diseases, Obstructive; Nifedipine; Ox | 1985 |
The role of vasodilators in patients with progressive systemic sclerosis. Interstitial lung disease and pulmonary hypertension.
Topics: Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Pulmonary Fibrosis; Sarcoid | 1985 |